B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Sgx 523

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Sgx 523, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

jnj
3 shared targets
tepotinib
2 shared targets
mk
5 shared targets
rigosertib
2 shared targets
osi
3 shared targets
lorecivivint
2 shared targets
demethylbellidifolin
2 shared targets
leucettamine
2 shared targets
gallocatechin
2 shared targets
t3
2 shared targets
Loading evidence profile...

This evidence profile for Sgx 523 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.